Equity Capital Markets

Company · CIK 1787297

Passage BIO, Inc.

CIK1787297 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressPA
ListedPASG (Nasdaq)
First annual or quarterly report2020-05-11

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-277632
ShelfEffective
 2024-03-042025-03-053
333-253955
ShelfEffective
 2021-03-052022-04-142
333-252213
Registered companyFinal prospectus
 2021-01-192021-01-223
333-236214
IPOFinal prospectus
 2020-02-032020-02-285

Filings

16
FiledFilingRegistrationAccession
2026-10-09EFFECTDeclared effective 333-2976019999999995-26-003198
2025-03-05424B5Shelf takedown 333-2776320001104659-25-020562
2024-04-16EFFECTDeclared effective 333-2776329999999995-24-000982
2024-03-04S-3Shelf registered 333-2776320001104659-24-030481
2022-04-14EFFECTDeclared effective 333-2539559999999995-22-000975
2021-03-05S-3ASRShelf registered 333-2539550001104659-21-032832
2021-01-22424B1Final prospectus 333-2522130001104659-21-006683
2021-01-21EFFECTDeclared effective 333-2522139999999995-21-000233
2021-01-19S-1Registration filed 333-2522130001104659-21-005296
2020-12-18DRSDraft made public 377-039110001104659-20-137415
2020-02-28424B4Final prospectus 333-2362140001047469-20-001117
2020-02-27EFFECTDeclared effective 333-2362149999999995-20-000432
2020-02-27S-1/AAmendment 333-2362140001047469-20-001071
2020-02-18S-1/AAmendment 333-2362140001047469-20-000894
2020-02-03S-1Registration filed 333-2362140001047469-20-000652
2019-12-06DRSDraft made public 377-029430000912057-19-000450

All filings of this company · CSV